Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NYSE:ESNT NYSE:LMND NYSE:OSCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$2.82+5.2%$2.07$1.58▼$3.92$1.48B2.445.86 million shs8.32 million shsESNTEssent Group$61.52+0.2%$60.15$55.22▼$67.09$5.78B0.81725,699 shs988,024 shsLMNDLemonade$54.54+2.9%$60.12$28.71▼$99.90$4.19B1.852.35 million shs1.70 million shsOSCROscar Health$20.81+4.9%$14.26$10.69▼$23.80$6.20B2.347.76 million shs12.32 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments+2.68%+3.88%+43.32%+31.37%-20.00%ESNTEssent Group+2.05%-3.94%+2.88%-5.88%+5.71%LMNDLemonade-7.34%-5.65%-14.48%-22.36%+74.83%OSCROscar Health+11.04%+11.31%+56.13%+59.52%+51.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$2.82+5.2%$2.07$1.58▼$3.92$1.48B2.445.86 million shs8.32 million shsESNTEssent Group$61.52+0.2%$60.15$55.22▼$67.09$5.78B0.81725,699 shs988,024 shsLMNDLemonade$54.54+2.9%$60.12$28.71▼$99.90$4.19B1.852.35 million shs1.70 million shsOSCROscar Health$20.81+4.9%$14.26$10.69▼$23.80$6.20B2.347.76 million shs12.32 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments+2.68%+3.88%+43.32%+31.37%-20.00%ESNTEssent Group+2.05%-3.94%+2.88%-5.88%+5.71%LMNDLemonade-7.34%-5.65%-14.48%-22.36%+74.83%OSCROscar Health+11.04%+11.31%+56.13%+59.52%+51.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.00Hold$2.902.84% UpsideESNTEssent Group 2.45Hold$67.8610.30% UpsideLMNDLemonade 2.22Hold$64.8818.95% UpsideOSCROscar Health 2.00Hold$18.22-12.44% DownsideCurrent Analyst Ratings BreakdownLatest CLOV, ESNT, OSCR, and LMND Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026OSCROscar Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$15.00 ➝ $20.005/7/2026OSCROscar Health BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$18.00 ➝ $21.005/7/2026OSCROscar Health Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$15.00 ➝ $19.005/5/2026OSCROscar Health Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoveragePeer Perform4/30/2026LMNDLemonade Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$65.00 ➝ $62.004/30/2026LMNDLemonade Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$85.00 ➝ $80.004/29/2026LMNDLemonade Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$98.00 ➝ $70.004/21/2026LMNDLemonade Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026OSCROscar Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/20/2026OSCROscar Health Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderperform ➝ Hold$10.00 ➝ $16.004/9/2026ESNTEssent Group JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$65.00 ➝ $64.00(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.92B0.77N/AN/A$0.59 per share4.78ESNTEssent Group$1.26B4.59$7.50 per share8.20$59.55 per share1.03LMNDLemonade$737.90M5.68N/AN/A$6.74 per share8.09OSCROscar Health$11.70B0.53N/AN/A$3.29 per share6.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$85.55M-$0.17N/AN/AN/A-4.45%-25.17%-14.81%N/AESNTEssent Group$689.97M$6.898.937.851.7154.72%12.09%9.45%5/8/2026 (Estimated)LMNDLemonade-$165.50M-$1.87N/AN/AN/A-16.44%-26.52%-7.18%N/AOSCROscar Health-$443.15M-$1.74N/A19.63N/A-3.79%-39.35%-7.29%N/ALatest CLOV, ESNT, OSCR, and LMND EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026ESNTEssent Group$1.72N/AN/AN/A$307.26 millionN/A5/6/2026Q1 2026CLOVClover Health Investments$0.07$0.05-$0.02$0.05$714.89 million$749.19 million5/6/2026Q1 2026OSCROscar Health$1.11$2.07+$0.96$2.07$4.90 billion$4.65 billion4/29/2026Q1 2026LMNDLemonade-$0.58-$0.47+$0.11-$0.47$251.51 million$258.00 million2/26/2026Q4 2025CLOVClover Health Investments-$0.05-$0.10-$0.05-$0.10$467.06 million$487.71 million2/18/2026Q4 2025LMNDLemonade-$0.41-$0.29+$0.12-$0.29$218.07 millionN/A2/14/2026Q4 2025ESNTEssent Group$1.74$1.60-$0.14$1.60$312.62 million$312.40 million2/10/2026Q4 2025OSCROscar Health-$0.92-$1.24-$0.32-$1.24$3.12 billion$2.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AESNTEssent Group$1.402.28%+14.14%20.32%6 YearsLMNDLemonadeN/AN/AN/AN/AN/AOSCROscar HealthN/AN/AN/AN/AN/ALatest CLOV, ESNT, OSCR, and LMND DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/13/2026ESNTEssent Groupquarterly$0.352.41%3/13/20263/13/20263/23/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.471.47ESNTEssent Group0.091.201.20LMNDLemonadeN/A0.860.86OSCROscar Health0.440.960.96Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%ESNTEssent Group93.00%LMNDLemonade80.30%OSCROscar Health75.70%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments24.07%ESNTEssent Group3.60%LMNDLemonade14.70%OSCROscar Health24.39%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680524.67 million398.38 millionOptionableESNTEssent Group35094.01 million90.63 millionOptionableLMNDLemonade1,28276.82 million65.53 millionOptionableOSCROscar Health2,305297.75 million225.13 millionOptionableCLOV, ESNT, OSCR, and LMND HeadlinesRecent News About These CompaniesWhy Oscar Health Stock Is Trending Right Now4 hours ago | kalkinemedia.comKWolfe Research initiates coverage of Oscar Health (OSCR) with peer perform recommendation4 hours ago | msn.comOscar Health reaffirms 2026 outlook with $18.7B-$19.0B revenue range as Q1 net income reaches $679M4 hours ago | seekingalpha.comRobert W. Baird Issues Positive Forecast for Oscar Health (NYSE:OSCR) Stock PriceMay 7 at 8:34 AM | marketbeat.comOscar Health, Inc. (OSCR) Q1 2026 Earnings Call TranscriptMay 6 at 8:15 PM | seekingalpha.comOscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly EarningsMay 6 at 8:15 PM | blockonomi.comOSCR stock pops pre-market on record quarterly income – retail traders say 'still undervalued' even at $30May 6 at 8:15 PM | msn.comOscar Health (NYSE:OSCR) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 12%May 6 at 8:15 PM | theglobeandmail.comOscar Health OSCR Q1 2026 Earnings TranscriptMay 6 at 8:15 PM | finance.yahoo.comOscar Health (OSCR) jumps after major earnings beat and margin improvementMay 6 at 8:15 PM | finance.yahoo.comOscar Health (NYSE:OSCR) Releases Earnings Results, Beats Estimates By $0.96 EPSMay 6 at 6:47 PM | marketbeat.comOscar Health Earnings Review: The Best Q1 Scenario We Could Hope ForMay 6 at 9:12 AM | seekingalpha.comOscar Health, Inc. (OSCR) Beats Q1 Earnings EstimatesMay 6 at 8:26 AM | zacks.comOscar Health Reports Record Profit As Obamacare Enrollment JumpsMay 6 at 7:01 AM | forbes.comOscar Health (OSCR) Q1 earnings: What to expectMay 5 at 3:43 AM | msn.comThis health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's howMay 4 at 2:11 PM | 247wallst.comOscar Health (OSCR) Projected to Post Quarterly Earnings on WednesdayMay 4 at 5:05 AM | americanbankingnews.comOscar Health, Inc. (NYSE:OSCR) Given Average Rating of "Hold" by BrokeragesMay 2, 2026 | americanbankingnews.comOscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of "Hold" from AnalystsMay 2, 2026 | marketbeat.comWhy Oscar Health, Inc. (OSCR) Outpaced the Stock Market TodayApril 30, 2026 | zacks.comInvestors Heavily Search Oscar Health, Inc. (OSCR): Here is What You Need to KnowApril 30, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLOV, ESNT, OSCR, and LMND Company DescriptionsClover Health Investments NASDAQ:CLOV$2.82 +0.14 (+5.22%) Closing price 04:00 PM EasternExtended Trading$2.80 -0.02 (-0.89%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Essent Group NYSE:ESNT$61.52 +0.11 (+0.18%) Closing price 03:59 PM EasternExtended Trading$61.70 +0.18 (+0.30%) As of 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Essent Group Ltd., through its subsidiaries, provides private mortgage insurance and reinsurance for mortgages secured by residential properties located in the United States. Its mortgage insurance products include primary, pool, and master policy. The company also provides information technology maintenance and development services; customer support-related services; underwriting consulting; and contract underwriting services, as well as risk management products and title insurance and settlement services. It serves the originators of residential mortgage loans, such as regulated depository institutions, mortgage banks, credit unions, and other lenders. Essent Group Ltd. was incorporated in 2008 and is based in Hamilton, Bermuda.Lemonade NYSE:LMND$54.54 +1.54 (+2.90%) Closing price 03:59 PM EasternExtended Trading$54.30 -0.24 (-0.44%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lemonade, Inc. provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, car, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York.Oscar Health NYSE:OSCR$20.81 +0.97 (+4.90%) Closing price 03:59 PM EasternExtended Trading$20.49 -0.32 (-1.55%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally IonQ Just Posted a Breakout Quarter—But 1 Problem Remains Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
